INVIZIO Trademark

Trademark Overview

On Wednesday, May 13, 2020, a trademark application was filed for INVIZIO with the United States Patent and Trademark Office. The USPTO has given the INVIZIO trademark a serial number of 88913606. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 23, 2023. This trademark is owned by Bayer Intellectual Property GmbH. The INVIZIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular diseases and kidney diseases
invizio

General Information

Serial Number88913606
Word MarkINVIZIO
Filing DateWednesday, May 13, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 23, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 28, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular diseases and kidney diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 27, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBayer Intellectual Property GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressMonheim am Rhein 40789
DE
Party NameBayer Intellectual Property GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address40789 Monheim am Rhein 40789
DE

Trademark Events

Event DateEvent Description
Monday, October 23, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 23, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 14, 2023SOU EXTENSION 5 GRANTED
Tuesday, February 28, 2023SOU EXTENSION 5 FILED
Tuesday, March 14, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 28, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 22, 2022SOU EXTENSION 4 GRANTED
Monday, August 22, 2022SOU EXTENSION 4 FILED
Monday, August 22, 2022SOU TEAS EXTENSION RECEIVED
Thursday, March 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 1, 2022SOU EXTENSION 3 GRANTED
Tuesday, March 1, 2022SOU EXTENSION 3 FILED
Tuesday, March 1, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, October 19, 2021ASSIGNED TO EXAMINER
Tuesday, September 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 3, 2021SOU EXTENSION 2 GRANTED
Friday, September 3, 2021SOU EXTENSION 2 FILED
Friday, September 3, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, February 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 29, 2021SOU EXTENSION 1 GRANTED
Friday, January 29, 2021SOU EXTENSION 1 FILED
Friday, January 29, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, September 22, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 28, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 24, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 24, 2020ASSIGNED TO EXAMINER
Wednesday, May 27, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 16, 2020NEW APPLICATION ENTERED

Related Keywords

invizio diseases kidney cardiovascular treatment preparations pharmaceutical